Under the Risk of COVID-19 Epidemic: A Study on the Influence of Life Attitudes, Leisure Sports Values, and Workplace Risk Perceptions on Urban Development and Public Well-Being

This study examined the impact of attitudes toward life, recreational sports values, and workplace risk perceptions on urban development and public well-being under the risk of the COVID-19 epidemic in China. A mixed-method research study was conducted, and 2400 valid questionnaires were collected via purposeful sampling. The questionnaires were analyzed using the SPSS 26.0 statistical software and validated with basic statistical methods and Pearson's correlation analysis. Semi-structured interviews were then conducted to collect the opinions of 12 respondents on the questionnaire results, including academics, foreign entrepreneurs and employees, local entrepreneurs and employees, and official institutions. Finally, all the data collected were discussed via triangulation analysis. The survey found that different cities' social and industrial development and job market needs lead to different attitudes toward life, leisure values, and perceptions of job-seeking and employment risks. The smoother a person's growing-up background, the better their learning history, the better their learning and working experience, and the richer their life experience;consequently, positive attitudes toward life, correct leisure values, and positive attitudes toward job hunting and employment can be cultivated. In addition, people with positive attitudes toward life, leisure values, and job hunting and employment can improve their city's economy and environment for sustainable development, thereby improving their quality of life and increasing their well-being.

Traditional Chinese medicine: an important broad-spectrum anti-coronavirus treatment strategy on COVID-19 background?

Coronaviruses exist widely in nature, can cause cross-species transmission, and pose serious threats to human and animal health. Over the past 20 years, coronaviruses have led to three major epidemics that have caused global panic, including severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease-19. At present, coronavirus disease-19 not only spreads rapidly, but also mutates easily to escape host immune response, becoming more pathogenic. At present, there are no effective specific therapeutic drugs or vaccines. Drugs targeting severe acute respiratory syndrome coronavirus 2 and the host cell defense system that have been developed based on the structure and replication cycle of coronaviruses have a certain broad-spectrum antiviral effect;however, their efficacy still needs to be demonstrated in further clinical trials. Traditional Chinese medicine has an indispensable role in the ongoing response to coronavirus disease-19. Anti-virus treatment with traditional Chinese medicine has advantages such as broad-spectrum application, low toxicity and side effects, low susceptibility to drug resistance, and overall comprehensive regulation. Therefore, researches on effective components and mechanisms of action of the anti-viral effects of traditional Chinese medicine have increasingly gained attention. The present paper examines coronaviruses, specifically summarizing the genomes, replication mechanisms, and mutant strains. Afterward, the therapeutic effects and mechanisms of action of modern broad-spectrum anti-coronavirus drugs and traditional Chinese medicine are summarized. By considering the virus and the targets in the host comprehensively, in addition to the beneficial multi-target and multi-path antiviral effects of traditional Chinese medicines, this paper could guide the development of treatment strategies for broad-spectrum anti-coronavirus traditional Chinese medicines, and could facilitate the modernization and globalization of traditional Chinese medicine.

[Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].

Objective: To explore a modified CT scoring system, its feasibility for disease severity evaluation and its predictive value in coronavirus disease 2019 (COVID-19) patients. Methods: This study was a multi-center retrospective cohort study. Patients confirmed with COVID-19 were recruited in three medical centers located in Beijing, Wuhan and Nanchang from January 27, 2020 to March 8, 2020. Demographics, clinical data, and CT images were collected. CT were analyzed by two emergency physicians of more than ten years' work experience independently through a modified scoring system. Final score was determined by average score from the two reviewers if consensus was not reached. The lung was divided into 6 zones (upper, middle, and lower on both sides) by the level of trachea carina and the level of lower pulmonary veins. The target lesion types included ground-glass opacity (GGO), consolidation, overall lung involvement, and crazy-paving pattern. Bronchiectasis, cavity, pleural effusion, etc., were not included in CT reading and analysis because of low incidence. The reviewers evaluated the extent of the targeted patterns (GGO, consolidation) and overall affected lung parenchyma for each zone, using Likert scale, ranging from 0-4 (0=absent; 1=1%-25%; 2=26%-50%; 3=51%-75%; 4=76%-100%). Thus, GGO score, consolidation score, and overall lung involvement score were sum of 6 zones ranging from 0-24. For crazy-paving pattern, it was only coded as absent or present (0 or 1) for each zone and therefore ranging from 0-6. Results: A total of 197 patients from 3 medical centers and 522 CT scans entered final analysis. The median age of the patients was 64 years, and 54.8% were male. There were 76(38.8%) patients had hypertension and 30(15.3%) patients had diabetes mellitus. There were 75 of the patients classified as moderate cases, as well as 95 severe cases and 27 critical cases. As initial symptom, dry cough occurred in 170 patients, 134 patients had fever, and 125 patients had dyspnea. Reparatory rate, oxygen saturation, lymphocyte count and CURB 65 score on admission day varied among patients with different disease severity scale. There were 50 of the patients suffered from deterioration during hospital stay. The median time consumed for each CT by clinicians was 86.5 seconds. Cronbach's alpha for GGO, consolidation, crazy-paving pattern, and overall lung involvement between two clinicians were 0.809, 0.712, 0.678, and 0.906, respectively, showing good or excellent inter-rater correlation. There were 193 (98.0%) patients had GGO, 147 (74.6%) had consolidation, and 126(64.0%) had crazy-paving pattern throughout clinical course. Bilateral lung involvement was observed in 183(92.9%) patients. Median time of interval for CT scan in our study was 7 days so that the whole clinical course was divided into stages by week for further analysis. From the second week on, the CT scores of various types of lesions in severe or critically patients were higher than those of moderate cases. After the fifth week, the course of disease entered the recovery period. The CT score of the upper lung zones was lower than that of other zones in moderate and severe cases. Similar distribution was not observed in critical patients. For moderate cases, the ground glass opacity score at the second week had predictive value for the escalation of the severity classification during hospitalization. The area under the receiver operating characteristic curve was 0.849, the best cut-off value was 5 points, with sensitivity of 84.2% and specificity of 75.0%. Conclusions: It is feasible for clinicians to use the modified semi-quantitative CT scoring system to evaluate patients with COVID-19. Severe/critical patients had higher scores for ground glass opacity, consolidation, crazy-paving pattern, and overall lung involvement than moderate cases. The ground glass opacity score in the second week had an optimal predictive value for escalation of disease severity during hospitalization in moderate patients on admission. The frequency of CT scan should be reduced after entering the recovery stage.

Antiviral properties of traditional chinese medicine against coronavirus: Research clues for coronavirus disease-2019

The objective of this study was to provide research clues for the prevention and treatment of coronavirus disease-2019 (COVID-19) and coronavirus (CoV) infection using Traditional Chinese Medicine (TCM). A review on research and clinical trials that using TCM extracts and active ingredients against CoV was performed, and a table of TCM agents and their effects on CoV were summarized. Relevant analysis was performed and visual expression of the data included summarizing the types of TCM and treatment methods for COVID-19. TCM fighting against CoV is mainly used in the lung and heart channels, and its medicinal properties are mainly cold and mild, while its taste is mainly bitter and sweet. The majority of research focused on treatments that clear away heat and toxic materials and those that strengthen body resistance and tonify deficiencies. TCM has unique advantages to fight against CoV. The development of new anti-CoV therapy using TCM is of great significance for the prevention and treatment of COVID-19 pneumonia and various viral infectious diseases.

Severe acute respiratory syndrome coronavirus 2 infection in renal transplant recipients: A case report

The novel coronavirus is a newly discovered pathogen in late December 2019, and its source is currently unknown, which can lead to asymptomatic infection, new coronavirus pneumonia or serious complications, such as acute respiratory failure. Corona virus disease 2019 (COVID-19) is a new type of respiratory disease that is currently spreading all over the world and caused by this coronavirus. Its common symptoms are highly similar to those of other viruses, such as fever, cough and dyspnea. There is currently no vaccine or treatment for COVID-19. Everyone is susceptible to infection with this disease, and owing to the long-term use of immunosuppressants, the immunity of kidney transplant recipients is suppressed, and it is more likely to be infected with the disease. At present, its impact on kidney transplant recipients is unclear. This article reports the clinical features and therapeutic course of novel coronavirus infection in a patient after renal transplantation. A 37-year-old female patient who received a kidney transplant 6 months before was diagnosed with novel coronavirus pneumonia. The patient's symptoms (such as fever, chills, dry cough, muscle aches), laboratory tests (such as decreased white blood cell count, elevated liver enzymes and D-dimer, positive viral nucleic acid test), and chest CT (multiple left lower lung plaque ground glass shadow) were similar to those of non-transplanted novel coronavirus pneumonia patients. In terms of treatment, because the immunity of kidney transplant recipients has been suppressed for a long time, it is a very common strategy to suspend the use of immunosuppressive agents. Therefore, the patient immediately discontinued the immunosuppressive agent after admission, so that she could restore immunity against infection in a short time. At the same time, the use of glucocorticoids was also very important. Its immunosuppressive and anti-inflammatory effects played a large role in the treatment process.In addition, prophylactic antibiotics was needed, and nephrotoxic drugs should be used with caution. Finally, following discounting the use of immunosuppressant and a low-dose glucocorticoid-based treatment regimen, COVID-19 in this renal transplant recipient was successfully cured. The cure of this case was of great significance, and this adjuvant nonspecific antiviral therapy could provide a template for the treatment of other such patients.